EICHORPublic-registry site landscape for NCT06410924, “A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH”, a NAFLD study sponsored by Neuraly, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT06410924 (registry record) |
| Study title | A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH |
| Official title | A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Treatment With DD01 for 48 Weeks in Overweight/Obese Subjects With MASLD/MASH |
| Sponsor | Neuraly, Inc. |
| Condition(s) | NAFLD; NASH |
| Phase | PHASE2 |
| Listed sites | 12 |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT06410924.
Eichor generates a preliminary site-risk snapshot for NCT06410924 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other NAFLD trials
More from Neuraly, Inc.
← Eichor home · All tracked trials · NAFLD studies · Weekly briefs
